Ivermectin Flops in Brazil
The peer-review New England Journal of Medicine journal recently published Original Article results showing early Ivermectin use in humans failed to reduce COVID-19 hospitalizations in patients in Brazil. Announced on March 30, 2022, this phase 3 clinical trial was double-blinded and randomized, the gold standard for research.